{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:04:49Z","timestamp":1788480289545,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtbi.2026.112533","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:28:52Z","timestamp":1781800132000},"page":"112533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Phenotypic plasticity and competition shape therapy sequencing in HER2+\/HER2\u2013 breast cancer: A mathematical framework"],"prefix":"10.1016","volume":"632","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9069-0999","authenticated-orcid":false,"given":"Aleksandra","family":"Gavrilova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2803-3341","authenticated-orcid":false,"given":"Trachette","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-5412","authenticated-orcid":false,"given":"Nizhum","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2026.112533_bib0001","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1172\/JCI74883","article-title":"Notch promotes recurrence of dormant tumor cells following HER2\/neu-targeted therapy","volume":"125","author":"Abravanel","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jtbi.2026.112533_bib0002","unstructured":"American Cancer Society, 2025. Cancer facts & figures 2025. American Cancer Society."},{"issue":"360","key":"10.1016\/j.jtbi.2026.112533_bib0003","article-title":"Notch-EGFR\/HER2 bidirectional crosstalk in breast cancer","volume":"4","author":"Baker","year":"2014","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.jtbi.2026.112533_bib0004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2026.112533_bib0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2026.112533_bib0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","article-title":"Clinical implications of intratumor heterogeneity: challenges and opportunities","volume":"98","author":"Cajal","year":"2020","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.jtbi.2026.112533_bib0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/GCO.0b013e3283414e87","article-title":"Her2-positive breast cancer: current management of early, advanced, and recurrent disease","volume":"23","author":"Callahan","year":"2011","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"7418","key":"10.1016\/j.jtbi.2026.112533_bib0008","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jtbi.2026.112533_bib0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0501-y","article-title":"Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in the bone microenvironment","volume":"121","author":"Capulli","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jtbi.2026.112533_bib0010","first-page":"1","article-title":"Frequency-dependent interactions determine outcome of competition between two breast cancer cell lines","volume":"11","author":"Freischel","year":"2021","journal-title":"Sci. Rep. 2021 11:1"},{"issue":"1","key":"10.1016\/j.jtbi.2026.112533_bib0011","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41540-025-00511-3","article-title":"Understanding therapeutic tolerance through a mathematical model of drug-induced resistance","volume":"11","author":"Gevertz","year":"2025","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.jtbi.2026.112533_bib0012","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1016\/j.celrep.2018.08.053","article-title":"Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer","volume":"24","author":"Granit","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.jtbi.2026.112533_bib0013","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41540-025-00571-5","article-title":"Optimal dosing of anti-cancer treatment under drug-induced plasticity","volume":"11","author":"Gunnarsson","year":"2025","journal-title":"NPJ Syst. Biol. Appl."},{"issue":"4","key":"10.1016\/j.jtbi.2026.112533_bib0014","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","article-title":"Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells","volume":"146","author":"Gupta","year":"2011","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.jtbi.2026.112533_bib0015","first-page":"3909","article-title":"Overcoming resistance to tumor-targeted and immune-targeted therapies","volume":"27","author":"Hata","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jtbi.2026.112533_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122922","article-title":"Targeting mtor and glycolysis in her2-positive breast cancer","volume":"13","author":"Holloway","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.jtbi.2026.112533_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110310","article-title":"Cell-state transitions and density-dependent interactions together explain the dynamics of spontaneous epithelial-mesenchymal heterogeneity","volume":"27","author":"Jain","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jtbi.2026.112533_bib0018","first-page":"1","article-title":"Experimentally-driven mathematical modeling to improve combination targeted and cytotoxic therapy for HER2+ breast cancer","volume":"9","author":"Jarrett","year":"2019","journal-title":"Sci. Rep. 2019 9:1"},{"key":"10.1016\/j.jtbi.2026.112533_bib0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature19328","article-title":"Her2 expression identifies dynamic functional states within circulating breast cancer cells","volume":"537","author":"Jordan","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2026.112533_bib0020","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2021.0803","article-title":"A mathematical model for phenotypic heterogeneity in breast cancer with implications for therapeutic strategies","volume":"19","author":"Li","year":"2022","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.jtbi.2026.112533_bib0021","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","article-title":"Intratumor heterogeneity: the rosetta stone of therapy resistance","volume":"37","author":"Marusyk","year":"2020","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.jtbi.2026.112533_bib0022","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jtbi.2026.112533_bib0023","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fonc.2018.00518","article-title":"Moving breast cancer therapy up a notch","volume":"8","author":"Mollen","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jtbi.2026.112533_bib0024","unstructured":"National Cancer Institute, 2025. SEER cancer stat facts: Common cancer sites. Accessed: 2025-07-15."},{"key":"10.1016\/j.jtbi.2026.112533_bib0025","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038508","article-title":"Her2\/pi3k\/akt pathway in her2-positive breast cancer: a review","volume":"103","author":"Pan","year":"2024","journal-title":"Medicine"},{"issue":"6797","key":"10.1016\/j.jtbi.2026.112533_bib0026","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.jtbi.2026.112533_bib0027","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2026.112533_bib0028","unstructured":"Rohatgi, A., 2026. Webplotdigitizer. https:\/\/automeris.io\/WebPlotDigitizer. Software for extracting data from plots."},{"key":"10.1016\/j.jtbi.2026.112533_bib0029","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.gendis.2016.02.002","article-title":"Cancer stem cells and HER2 positive breast cancer: the story so far","volume":"3","author":"Shah","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.jtbi.2026.112533_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.suronc.2020.04.017","article-title":"Cell plasticity in cancer: a complex interplay of genetic, epigenetic mechanisms and tumor micro-environment","volume":"34","author":"Shenoy","year":"2020","journal-title":"Surg. Oncol."},{"issue":"5","key":"10.1016\/j.jtbi.2026.112533_bib0031","first-page":"1123","article-title":"Trends in cancer incidence and mortality rates in early-onset and older-onset age groups in the united states, 2010-2019","volume":"15","author":"Shiels","year":"2025","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.jtbi.2026.112533_bib0032","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.jtbi.2026.112533_bib0033","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jtbi.2026.112533_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104317","article-title":"Emergence of hybrid states of stem-like cancer cells correlates with poor prognosis in oral cancer","volume":"25","author":"Vipparthi","year":"2022","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.jtbi.2026.112533_bib0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13058-016-0795-0","article-title":"The glucose transporter GLUT1 is required for erbb2-induced mammary tumorigenesis","volume":"18","author":"Wellberg","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jtbi.2026.112533_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101041","article-title":"Furin, ADAM, and \u03b3-secretase: core regulatory targets in the notch pathway and the therapeutic potential for breast cancer","volume":"57","author":"Yao","year":"2024","journal-title":"Neoplasia"}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002251932600158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002251932600158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:10:22Z","timestamp":1783170622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002251932600158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S002251932600158X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2026.112533","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic plasticity and competition shape therapy sequencing in HER2+\/HER2\u2013 breast cancer: A mathematical framework","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2026.112533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112533"}}